KaydedilenlerDerginizi ekleyin

Dergiler / Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi / 2022 / Cilt: 17 - Sayı: 3

Sekretuar Meningiom: Radyolojik ve Patolojik Olarak Malign Tümörlerle Karıştırılabilen Nadir Bir Antite

Secretory Meningioma: A Rare Entity That Can Be Confused Radiologically and Pathologically with Malignant Tumors

Meryem İlkay EREN KARANİS
İlknur KÜÇÜKOSMANOĞLU
İlker ÇÖVEN
Sayfa
235–238
Yayın Tarihi
2022-11-02
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗

Özet

Özet

Abstract

Abstract

🔖

Bu Makaleye Atıf Yap

KARANİS, M. İ. E., KÜÇÜKOSMANOĞLU, İ., ÇÖVEN, İ. (2022). Sekretuar Meningiom: Radyolojik ve Patolojik Olarak Malign Tümörlerle Karıştırılabilen Nadir Bir Antite. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, Cilt: 17 - Sayı: 3, 235–238. https://ajindex.com/articles/783109

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Perry A, Louis DN, Budka H, von Deimling A, Sahm F, Rushing EJ et al. Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds), WHO Clasification of Tumours of Central Nervous System, Lyon: IARC Press; 2016. P:239-240. Probst‐Cousin S, Villagran‐Lillo R, Lahl R, Bergmann M, Schmid KW, Gullotta F. Secretory meningioma: Clinical, histologic, and immunohistochemical findings in 31 cases. Cancer. 1997;79(10):2003-2015.
  2. Colakoğlu N, Demirtas E, Oktar N, Yuntem N, Iskelek S, Ozdamar N. Secretory Meningiomas. J Neurooncol. 2003;62:233-241.
  3. Buhl R, Hugo HH, Mihajlovic Z, Maximilian Mehdorn H. Secretory meningiomas: Clinical and immunohistochemical observations. Neurosurgery. 2001;48(2):297-302.
  4. Mohme M, Emami P, Matschke J, Regelsberger J, Westphal M, Eicker SO. Secretory Meningiomas: Characteristic Features and clinical management of a unique subgroup. Neurosurg Clin N Am. 2016;27(2):181-187.
  5. Reuss DE, Piro RM, Jones DT, Simon M, Ketter R, Kool M et al. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta neuropathologica. 2013;125(3):351-358.
  6. Nishio S, Morioka T, Suzuki S, Hirano K, Fukui M. Secretory meningioma: Clinicopathologic features of eight cases. Journal of clinical neuroscience. 2001;8(4):335-339.
  7. Canda MŞ, Güray M, Acar ÜD. The histopathologic and the immunohistochemical features of secretory meningiomas. Turk J Med Sci. 2001;31:279-282.
  8. Wang DJ, Xie Q, Gong Y, Wang Y, Cheng HX, Mao Y et al. Secretory meningiomas: Clinical, radiological and pathological findings in 70 consecutive cases at one institution. International journal of clinical and experimental pathology. 2013;6(3):358. Csonka T, Murnyák B, Szepesi R, Bencze J, Bognár L, Klekner Á et al. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence. Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 2016;54(2):114-126.
  9. Tirakotai W, Mennel HD, Celik I, Hellwig D, Bertalanffy H, Riegel T. Secretory meningioma: Immunohistochemical findings and evaluation of mast cell infiltration. Neurosurgical review. 2006;29(1):41-48.
  10. Regelsberger J, Hagel C, Emami P, Ries T, Heese O, Westphal M. Secretory meningiomas: A benign subgroup causing life-threatening complications. Neuro-oncology. 2009;11(6):819-824.